Primary Human Macrophage and Tenocyte Tendon Healing Phenotypes Changed by Exosomes Per Cell Origin
Tissue Engineering Part A · 2025
DOI: 10.1089/ten.tea.2024.0143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part A, 2025. Verfasst von Devin von Stade und 6 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic and Bioengineering Research Laboratory, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Exosomes, Macrophages, Wound Healing, Tenocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
The high failure rate of surgical repair for tendinopathies has spurred interest in adjunct therapies, including exosomes (EVs). Mesenchymal stromal cell (MSC)-derived EVs (MSCdEVs) have been of particular interest as they improve several metrics of tendon healing in animal models. However, research has shown that EVs derived from tissue-native cells, such as tenocytes, are functionally distinct and may better direct tendon healing. To this end, we investigated the differential regulation of human primary macrophage transcriptomic responses and cytokine secretion by tenocyte-derived EVs (TdEVs) compared with MSCdEVs. Compared with MSCdEVs, TdEVs upregulated TNFa-NFkB and TGFB signaling and pathways associated with osteoclast differentiation in macrophages while decreasing secretion of several pro-inflammatory cytokines. Conditioned media of these TdEV educated macrophages drove increased tenocyte migration and decreased MMP3 and MMP13 expression. In contrast, MSCdEV education of macrophages drove increased gene expression pathways related to INFa, INFg and protection against oxidative stress while increasing cytokine expression of MCP1 and IL6. These data demonstrate that EV cell source differentially impacts the function of key effector cells in tendon healing and that TdEVs, compared with MSCdEVs, promote a more favorable tendon healing phenotype within these cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Orthopaedic and Bioengineering Research Laboratory, Colorado State University, Fort Collins, Colorado, USA.
- Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, Colorado, USA.
- American Orthopedic Partners, Denver, Colorado, USA.
- Shoulder Elbow Sports Medicine, Chicago, Illinois, USA.
- Flint Animal Cancer Center and Dept. of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.
ORCID-Profile: Devin von Stade
Zitieren
APA
von Stade, D., Meyers, M., Johnson, J., Schlegel, T., Romeo, A., Regan, D., & McGilvray, K. (2025). Primary Human Macrophage and Tenocyte Tendon Healing Phenotypes Changed by Exosomes Per Cell Origin. Tissue Engineering Part A. https://doi.org/10.1089/ten.tea.2024.0143
Vancouver
von Stade D, Meyers M, Johnson J, Schlegel T, Romeo A, Regan D, et al. Primary Human Macrophage and Tenocyte Tendon Healing Phenotypes Changed by Exosomes Per Cell Origin. Tissue Engineering Part A. 2025. doi:10.1089/ten.tea.2024.0143
BibTeX
@article{vonStade2025,
author = {von Stade, Devin and Meyers, Melinda and Johnson, James and Schlegel, Theodore and Romeo, Anthony and Regan, Daniel and McGilvray, Kirk},
title = {Primary Human Macrophage and Tenocyte Tendon Healing Phenotypes Changed by Exosomes Per Cell Origin},
journal = {Tissue Engineering Part A},
year = {2025},
doi = {10.1089/ten.tea.2024.0143}
}
EUVIMED